$INVX
Innovex International, Inc.

2024 Q3 Form 10-Q Financial Statement

#000095017024092740 Filed on August 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $151.8M $120.3M
YoY Change 29.49% 34.3%
Cost Of Revenue $99.14M $83.23M
YoY Change 15.81% 26.66%
Gross Profit $52.68M $37.11M
YoY Change 66.49% 55.31%
Gross Profit Margin 34.7% 30.84%
Selling, General & Admin $37.98M $29.77M
YoY Change 40.72% 28.06%
% of Gross Profit 72.1% 80.22%
Research & Development $3.588M
YoY Change 12.05%
% of Gross Profit 9.67%
Depreciation & Amortization $7.786M $8.007M
YoY Change -1.43% 13.59%
% of Gross Profit 14.78% 21.57%
Operating Expenses $37.98M $29.77M
YoY Change 40.72% 12.56%
Operating Profit -$13.22M -$4.666M
YoY Change 117.72% 82.69%
Interest Expense $729.0K -$4.618M
YoY Change -41.77% -168.0%
% of Operating Profit
Other Income/Expense, Net $269.0K $133.0K
YoY Change -533.87%
Pretax Income $80.00M -$2.613M
YoY Change -2228.2% -146.79%
Income Tax -$2.587M -$801.0K
% Of Pretax Income -3.23%
Net Earnings $82.59M -$1.812M
YoY Change -1274.1% -152.02%
Net Earnings / Revenue 54.4% -1.51%
Basic Earnings Per Share $2.03 -$0.05
Diluted Earnings Per Share $1.99 -$0.05
COMMON SHARES
Basic Shares Outstanding 34.45M 34.42M
Diluted Shares Outstanding 41.53M 34.44M

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $99.90M $185.6M
YoY Change -47.42% -27.29%
Cash & Equivalents $99.90M $185.6M
Short-Term Investments $0.00
Other Short-Term Assets $4.226M $8.006M
YoY Change -76.65% -86.82%
Inventory $297.5M $204.7M
Prepaid Expenses $16.92M
Receivables $225.1M $154.2M
Other Receivables $0.00 $0.00
Total Short-Term Assets $677.3M $707.6M
YoY Change -4.47% -6.3%
LONG-TERM ASSETS
Property, Plant & Equipment $182.2M $211.1M
YoY Change -13.96% 10.05%
Goodwill $23.93M $16.10M
YoY Change 47.73%
Intangibles $38.85M
YoY Change 76.1%
Long-Term Investments $19.92M
YoY Change
Other Assets $7.704M $7.497M
YoY Change 30.42% -29.35%
Total Long-Term Assets $455.5M $300.6M
YoY Change 52.57% 33.89%
TOTAL ASSETS
Total Short-Term Assets $677.3M $707.6M
Total Long-Term Assets $455.5M $300.6M
Total Assets $1.133B $1.008B
YoY Change 12.43% 2.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $83.61M $60.83M
YoY Change 65.72% 11.79%
Accrued Expenses $55.88M $54.35M
YoY Change 34.41% 135.86%
Deferred Revenue $14.09M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $10.70M
YoY Change
Total Short-Term Liabilities $174.8M $126.4M
YoY Change 63.77% 43.47%
LONG-TERM LIABILITIES
Long-Term Debt $12.35M $0.00
YoY Change
Other Long-Term Liabilities $1.962M $4.599M
YoY Change -42.72% -39.65%
Total Long-Term Liabilities $53.63M $4.599M
YoY Change 1465.75% -39.65%
TOTAL LIABILITIES
Total Short-Term Liabilities $174.8M $126.4M
Total Long-Term Liabilities $53.63M $4.599M
Total Liabilities $228.4M $155.6M
YoY Change 66.61% 55.23%
SHAREHOLDERS EQUITY
Retained Earnings $179.5M $929.0M
YoY Change -81.09% -2.82%
Common Stock $723.2M $106.7M
YoY Change 634.1% 11.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $904.4M $852.5M
YoY Change
Total Liabilities & Shareholders Equity $1.133B $1.008B
YoY Change 12.43% 2.91%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $82.59M -$1.812M
YoY Change -1274.1% -152.02%
Depreciation, Depletion And Amortization $7.786M $8.007M
YoY Change -1.43% 13.59%
Cash From Operating Activities $70.50M -$9.304M
YoY Change 203.44% -182.47%
INVESTING ACTIVITIES
Capital Expenditures -$4.946M $6.156M
YoY Change -191.09% -39.57%
Acquisitions
YoY Change
Other Investing Activities $130.0M $4.148M
YoY Change -282.13% 357.84%
Cash From Investing Activities $134.9M -$2.008M
YoY Change -275.69% -78.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -113.7M -178.0K
YoY Change 598515.79% 1518.18%
NET CHANGE
Cash From Operating Activities 70.50M -9.304M
Cash From Investing Activities 134.9M -2.008M
Cash From Financing Activities -113.7M -178.0K
Net Change In Cash 91.66M -11.49M
YoY Change -271.11% -677.39%
FREE CASH FLOW
Cash From Operating Activities $70.50M -$9.304M
Capital Expenditures -$4.946M $6.156M
Free Cash Flow $75.45M -$15.46M
YoY Change 323.77% -1511.87%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001042893
dei Entity Address Country
EntityAddressCountry
US
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P0Y
us-gaap Restructuring Incurred Cost Statement Of Income Or Comprehensive Income Extensible Enumeration
RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://www.dril-quip.com/20240630#RestructuringAndOtherCharges
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-13439
dei Entity Registrant Name
EntityRegistrantName
DRIL-QUIP, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
74-2162088
dei Entity Address Address Line1
EntityAddressAddressLine1
2050 West Sam Houston Parkway S.
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1100
dei Entity Address City Or Town
EntityAddressCityOrTown
Houston
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77042
dei City Area Code
CityAreaCode
713
dei Local Phone Number
LocalPhoneNumber
939-7711
dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value per share
dei Trading Symbol
TradingSymbol
DRQ
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
34452230
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
185629000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
187323000
CY2024Q2 us-gaap Restricted Cash
RestrictedCash
3590000
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
4077000
CY2024Q2 us-gaap Short Term Investments
ShortTermInvestments
0
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
25908000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
154183000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
135569000
CY2024Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
132979000
CY2023Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
148429000
CY2024Q2 us-gaap Inventory Net
InventoryNet
204733000
CY2023Q4 us-gaap Inventory Net
InventoryNet
194593000
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
16917000
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
14119000
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
8006000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
9699000
CY2024Q2 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
1513000
CY2023Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
0
CY2024Q2 us-gaap Assets Current
AssetsCurrent
707550000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
719717000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16779000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16343000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
211117000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
217631000
CY2024Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
10242000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
8989000
CY2024Q2 us-gaap Goodwill
Goodwill
16122000
CY2023Q4 us-gaap Goodwill
Goodwill
16654000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
38850000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
41941000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7497000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6906000
CY2024Q2 us-gaap Assets
Assets
1008157000
CY2023Q4 us-gaap Assets
Assets
1028181000
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
60833000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
60160000
CY2024Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3291000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
5942000
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
7960000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
7583000
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14564000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14035000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2454000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2118000
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
37327000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
27865000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
126429000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
117703000
CY2024Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
9189000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
10564000
CY2024Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
472000
CY2023Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
346000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14944000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14554000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4599000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3754000
CY2024Q2 us-gaap Liabilities
Liabilities
155633000
CY2023Q4 us-gaap Liabilities
Liabilities
146921000
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34452230
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34452230
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34386577
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34386577
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
343000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
343000
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
106403000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
100289000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
928977000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
950719000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-183199000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-170091000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
852524000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
881260000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1008157000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1028181000
CY2024Q2 us-gaap Revenues
Revenues
120342000
CY2023Q2 us-gaap Revenues
Revenues
89607000
us-gaap Revenues
Revenues
230640000
us-gaap Revenues
Revenues
180472000
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
83229000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
65711000
us-gaap Cost Of Revenue
CostOfRevenue
161649000
us-gaap Cost Of Revenue
CostOfRevenue
131213000
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
29771000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
22114000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
59762000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
44699000
CY2024Q2 drq Engineering And Product Development
EngineeringAndProductDevelopment
3588000
CY2023Q2 drq Engineering And Product Development
EngineeringAndProductDevelopment
3202000
drq Engineering And Product Development
EngineeringAndProductDevelopment
7326000
drq Engineering And Product Development
EngineeringAndProductDevelopment
6601000
CY2024Q2 drq Restructuring And Other Charges
RestructuringAndOtherCharges
0
CY2023Q2 drq Restructuring And Other Charges
RestructuringAndOtherCharges
-610000
drq Restructuring And Other Charges
RestructuringAndOtherCharges
0
drq Restructuring And Other Charges
RestructuringAndOtherCharges
1108000
CY2024Q2 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-54000
CY2023Q2 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
738000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
146000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
7385000
CY2024Q2 drq Acqusition Costs
AcqusitionCosts
1695000
CY2023Q2 drq Acqusition Costs
AcqusitionCosts
1134000
drq Acqusition Costs
AcqusitionCosts
20742000
drq Acqusition Costs
AcqusitionCosts
1134000
CY2024Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-6671000
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
4812000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-4775000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
3692000
CY2024Q2 us-gaap Costs And Expenses
CostsAndExpenses
125008000
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
86001000
us-gaap Costs And Expenses
CostsAndExpenses
254108000
us-gaap Costs And Expenses
CostsAndExpenses
173678000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4666000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
3606000
us-gaap Operating Income Loss
OperatingIncomeLoss
-23468000
us-gaap Operating Income Loss
OperatingIncomeLoss
6794000
CY2024Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
2053000
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1979000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
4249000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
4726000
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2613000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5585000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19219000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11520000
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-801000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2102000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2577000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5726000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-1812000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
3483000
us-gaap Net Income Loss
NetIncomeLoss
-21796000
us-gaap Net Income Loss
NetIncomeLoss
5794000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.1
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.63
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.1
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.63
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34437000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34130000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34427000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34129000
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34437000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34490000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34427000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34488000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-1812000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
3483000
us-gaap Net Income Loss
NetIncomeLoss
-21796000
us-gaap Net Income Loss
NetIncomeLoss
5794000
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6405000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4454000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-13054000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3880000
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8217000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-971000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-34850000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1914000
us-gaap Net Income Loss
NetIncomeLoss
-21796000
us-gaap Net Income Loss
NetIncomeLoss
5794000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16439000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13938000
us-gaap Share Based Compensation
ShareBasedCompensation
6166000
us-gaap Share Based Compensation
ShareBasedCompensation
5143000
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
0
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
-841000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
146000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
7385000
drq Business Acqusition Cost Under Operating Activities
BusinessAcqusitionCostUnderOperatingActivities
16166000
drq Business Acqusition Cost Under Operating Activities
BusinessAcqusitionCostUnderOperatingActivities
0
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4097000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
734000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
19754000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
42446000
drq Increase Decrease In Unbilled Receivable
IncreaseDecreaseInUnbilledReceivable
-5200000
drq Increase Decrease In Unbilled Receivable
IncreaseDecreaseInUnbilledReceivable
-6356000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12214000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
15331000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
7322000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1652000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8001000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-9252000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-51000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
0
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13408000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-41638000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10913000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15611000
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
507000
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
16240000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
20462000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
25908000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
33899000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
15502000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
14066000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-475000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-22000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-475000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-22000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-3800000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-720000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2181000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-28314000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
191400000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
264804000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
189219000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
236490000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
857363000
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-6405000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-1812000
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8217000
CY2024Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
3378000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
852524000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
881260000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-13054000
us-gaap Net Income Loss
NetIncomeLoss
-21796000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-34850000
drq Shares With Held For Payment Of Employee Payroll Taxes
SharesWithHeldForPaymentOfEmployeePayrollTaxes
-52000
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
6166000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
852524000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
877814000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-4454000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
3483000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-971000
CY2023Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
2566000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
879409000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
872352000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-3880000
us-gaap Net Income Loss
NetIncomeLoss
5794000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1914000
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
5143000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
879409000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-indent:2.4%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Reclassifications</span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We reclassified approximately</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">5.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of accrued professional fees for the year ended December 31, 2023, from accounts payable to other accrued liabilities to conform to our cu</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">rrent year presentation. These reclassifications to the prior period were made to conform to the current period presentation and did not have an impact on our consolidated statements of income (loss), consolidated balance sheets, consolidated statements of comprehensive income (loss), consolidated statements of stockholders’ equity and consolidated statements of cash flows.</span></p>
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
5500000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:2.4%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities as of the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates. Some of the Company’s more significant estimates are those affected by critical accounting policies for revenue recognition and asset recoverability tests and inventories</span>
CY2024Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
3600000
drq Amount To Maintain Cash Collateral Account For Letters Of Credit
AmountToMaintainCashCollateralAccountForLettersOfCredit
the outstanding letters of credit plus 5% at all times
CY2022Q1 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
100000000
CY2024Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
CY2023Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34437000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34130000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34427000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34129000
CY2024Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
360000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
359000
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34437000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34490000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34427000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34488000
CY2024Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
1170000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
1208000
CY2024Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1170000
CY2023Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1208000
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1182000
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1208000
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0
CY2024Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
0
CY2023Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
0
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
0
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
0
CY2024Q2 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0
CY2023Q2 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0
CY2024Q2 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
0
CY2023Q2 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
0
us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
0
us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
0
CY2024Q2 us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
-12000
CY2023Q2 us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
0
us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
-38000
us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
0
CY2024Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1170000
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0
CY2024Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1170000
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
144191000
us-gaap Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
198055000
us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
213176000
CY2024Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
129070000
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
40200000
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.977
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.023
CY2024Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
35465000
CY2023Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
34950000
CY2024Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
31226000
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
33911000
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
138042000
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
125732000
CY2024Q2 us-gaap Inventory Net
InventoryNet
204733000
CY2023Q4 us-gaap Inventory Net
InventoryNet
194593000
CY2024Q2 drq Reduction In Raw Materials By Reserve
ReductionInRawMaterialsByReserve
-6200000
CY2024Q2 drq Reduction In Work In Progress By Reserve
ReductionInWorkInProgressByReserve
-3300000
CY2024Q2 drq Reduction In Finished Goods By Reserve
ReductionInFinishedGoodsByReserve
-58600000
CY2023Q4 drq Reduction In Raw Materials By Reserve
ReductionInRawMaterialsByReserve
-8300000
CY2023Q4 drq Reduction In Work In Progress By Reserve
ReductionInWorkInProgressByReserve
-2700000
CY2023Q4 drq Reduction In Finished Goods By Reserve
ReductionInFinishedGoodsByReserve
-55200000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2024Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
630000
us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
0
us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
-600000
drq Accrued Restructuring And Other Charges
AccruedRestructuringAndOtherCharges
-30000
CY2024Q2 us-gaap Restructuring Reserve
RestructuringReserve
0
CY2023Q4 us-gaap Goodwill
Goodwill
16700000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-600000
CY2024Q2 us-gaap Goodwill
Goodwill
16100000
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
62313000
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
22787000
CY2024Q2 drq Finite Lived Intangible Assets Accumulated Foreign Currency Translation Gain Loss
FiniteLivedIntangibleAssetsAccumulatedForeignCurrencyTranslationGainLoss
-676000
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
38850000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
62231000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
20269000
CY2023Q4 drq Finite Lived Intangible Assets Accumulated Foreign Currency Translation Gain Loss
FiniteLivedIntangibleAssetsAccumulatedForeignCurrencyTranslationGainLoss
-21000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
41941000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2024Q2 us-gaap Revenues
Revenues
120342000
CY2023Q2 us-gaap Revenues
Revenues
89607000
us-gaap Revenues
Revenues
230640000
us-gaap Revenues
Revenues
180472000
CY2024Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8007000
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7049000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16439000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13938000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4666000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
3606000
us-gaap Operating Income Loss
OperatingIncomeLoss
-23468000
us-gaap Operating Income Loss
OperatingIncomeLoss
6794000
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.307
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.134
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.376
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.497
CY2023Q4 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
0
CY2024Q2 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
0
CY2024Q2 us-gaap Deferred Tax Liabilities Undistributed Foreign Earnings
DeferredTaxLiabilitiesUndistributedForeignEarnings
1300000
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-092740-index-headers.html Edgar Link pending
0000950170-24-092740-index.html Edgar Link pending
0000950170-24-092740.txt Edgar Link pending
0000950170-24-092740-xbrl.zip Edgar Link pending
drq-20240630.htm Edgar Link pending
drq-20240630.xsd Edgar Link pending
drq-ex31_1.htm Edgar Link pending
drq-ex31_2.htm Edgar Link pending
drq-ex32_1.htm Edgar Link pending
drq-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
drq-20240630_htm.xml Edgar Link completed
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending